TSLP Receptor Antibody 14-5499-82 from Thermo Fisher Scientific | Biocompare.com

Supplier Images

Flow

Staining of human TSLP Receptor transfected cells with 0.25 µg of Mouse IgG2a K Isotype Control Purified (Product # 14-4724-82) (open histogram) or 0.25 µg of Anti-Human TSLP Receptor Purified (filled histogram) followed by Anti-Mouse IgG Biotin (Product # 13-4013-85) and Streptavidin PE (Product # 12-4317-87). Total viable cells were used for analysis.
Flow

Staining of human TSLP Receptor transfected cells with 0.25 µg of Mouse IgG2a K Isotype Control Purified (Product # 14-4724-82) (open histogram) or 0.25 µg of Anti-Human TSLP Receptor Purified (filled histogram) followed by Anti-Mouse IgG Biotin (Product # 13-4013-85) and Streptavidin PE (Product # 12-4317-87). Total viable cells were used for analysis.

Be the first to write a review!

Citations:

Supplier Page from
Thermo Fisher Scientific for
TSLP Receptor Antibody

Thermo Fisher Scientific's TSLP Receptor Antibody is a Mouse monoclonal antibody. The TSLP Receptor Antibody was generated using CRLF2 as the antigen. It reacts with Homo Sapiens, and Human. This antibody has been shown to work in applications such as: Flow Cytometry, and Western Blot.

Product Specs
ItemTSLP Receptor Antibody
CompanyThermo Fisher Scientific
Price Pricing Info Supplier Page View Company Product Page
Catalog Number14-5499-82
Quantity100 µg
ApplicationsFlow Cytometry, Western Blot
Concentration0.5 mg/mL
Conjugate/TagUnconjugated
FormatPBS with 0.09% sodium azide; pH 7.2
ReactivityHuman
TargetTSLP Receptor
IsotypeIgG2a lambda
CloneeBio1A6 (1A6)
HostMouse
NCBI Full Gene Namecytokine receptor like factor 2
NCBI Gene AliasesCRL2, CRLF2Y, TSLPR
ClonalityMonoclonal
PurityAffinity chromatography
Storage Temperature4° C
Antibody TypePrimary
Storage4° C

Add to Compare List

Thermo Fisher Scientific

Thermo Fisher Scientific

Thermo Fisher Scientific

81 Wyman Street

Waltham, MA 02451

United States

Phone: 800-678-5599
Fax: 800-331-2286

Company Profile

Website: www.thermofisher.com

(1) Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic LeukemiaCancer cellJuly 13, 2015Wu SC, Li LS, Kopp N, Montero J, Chapuy B, Yoda A, Christie AL, Liu H, Christodoulou A, van Bodegom D, et al.

(2) BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemiaBloodOctober 4, 2012Ott CJ, Kopp N, Bird L, Paranal RM, Qi J, Bowman T, Rodig SJ, Kung AL, Bradner JE, Weinstock DM.

(3) Mutations in the transmembrane and juxtamembrane domains enhance IL27R transforming activityThe Biochemical journalAugust 15, 2011Lambert QT, Pradhan A, Roll JD, Reuther GW.

Be the First to Write a Review!